These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1175200)

  • 1. [Antibodies and fibrinolysis in ischaemic heart disease (author's transl)].
    Pokorný J; Jezková Z; Dosková M
    Cas Lek Cesk; 1975 Aug; 114(34-35):1079-82. PubMed ID: 1175200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary heart disease, standard bicycle ergometry, and hemostatic function (author's transl)].
    Zöller H; Dietz A; Kloppenburg M
    Med Klin; 1978 Jan; 73(3):96-100. PubMed ID: 622063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on coagulative and fibrinolytic dynamics during aorto-coronary bypass procedure (author's transl)].
    Kitajima T; Yoshinaka A; Ogata H
    Masui; 1980 Jun; 29(6):547-52. PubMed ID: 6967525
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological studies in peripheral vascular diseases and in ischaemic heart disease.
    Jezková Z; Pokorný J
    Acta Univ Carol Med (Praha); 1969; 15(1):101-23. PubMed ID: 5772506
    [No Abstract]   [Full Text] [Related]  

  • 5. The content of immunoglobulins, auto-antibodies, myocardial antigen and immune complexes in patients with ischaemic heart disease in relationship to the state of circulation.
    Baranovskii PV
    Cor Vasa; 1986; 28(3):181-5. PubMed ID: 2427275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of three serological methods for determination of antistreptokinase following fibrinolytic therapy (author's transl)].
    Knöll H; Gerlach D; Knöll P; Vogel G
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):313-9. PubMed ID: 352035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood lipid levels as indicators of risk in the epidemiology of ischaemic heart disease (author's transl)].
    Pokorný J; Jezková Z
    Sb Lek; 1974 Jan; 76(1):1-7. PubMed ID: 4842894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of an anti-atherosclerotic diet with a high protein concentration on fibrinolysis in patients with ischemic heart disease].
    Samsonov MA; Andreenko GV; Paramonova EG; Karabasova MA
    Vopr Pitan; 1976; (5):34-9. PubMed ID: 982944
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum fibrinolytic activity and recalcified plasma clotting time in ischaemic heart disease.
    Arora A; Gupta JC; Arora MM
    J Indian Med Assoc; 1969 Nov; 53(10):477-82. PubMed ID: 5368384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet aggregation and fibrinolysis in patients with ischemic heart disease at rest and after exercise (author's transl)].
    Nagakawa Y
    Nihon Ronen Igakkai Zasshi; 1980 Jan; 17(1):29-38. PubMed ID: 7373931
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol, platelets adhesiveness and fibrinolytic activity in ischaemic heart disease.
    Gupta KK
    J Assoc Physicians India; 1969 May; 17(5):323-31. PubMed ID: 5350177
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparative investigation of the presence of heart reactive antibodies in rheumatic heart disease as index of activity: human and monkey heart antigen in the consumption test and immunofluorescence test (author's transl)].
    Gaul G; Ludwig H; Steffen C
    Wien Klin Wochenschr; 1974 Oct; 86(18):532-9. PubMed ID: 4605468
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the share of phosphatidylcholine in total phospholipid concentration in patients with ischaemic heart disease and after myocardial infarction (author's transl)].
    Votruba M; Schmidtová H; Rouchal J; Vacková V
    Cas Lek Cesk; 1981 Jul; 120(27):823-5. PubMed ID: 7261003
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
    Teger-Nilsson AC; Larsson PT; Hjemdahl P; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI72-7. PubMed ID: 1683612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
    Sarno A; La Bruzzo S; Catania A; Francavilla G; Romano A; Caimi G
    G Ital Cardiol; 1980; 10(1):65-71. PubMed ID: 7461310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiac antibodies in ischaemic heart disease.
    Sharma SS; Kumar S; Kunwar KB; Mehrotra RM; Chaturvedi UC; Mitra MK
    J Assoc Physicians India; 1970 Jul; 18(7):595-601. PubMed ID: 5473874
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood fibrinolytic system in health subjects and elderly patients with ischemic heart disease].
    Korkushko OV; Kovalenko AN
    Ter Arkh; 1980; 52(8):15-9. PubMed ID: 7256585
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vineberg's operation in ischaemic heart disease (author's transl)].
    Pavrovský J; Lichtenberg J; Vancura J; Vanousová E; Kucera M; Jezek V
    Sb Lek; 1974 Jan; 76(1):8-14. PubMed ID: 4546289
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ischaemic heart disease and the body build (author's transl)].
    Cerovská J
    Cas Lek Cesk; 1980 May; 119(20-21):593-7. PubMed ID: 7407829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.